Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience
Immacolata Capasso(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Antonio Giordano(University of Siena), Tonino Pedicini(Serviço Nacional de Aprendizagem Comercial), Giuseppe Esposito(Sapienza University of Rome), Ernesta Cavalcanti(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Massimiliano D’Aiuto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Maria Grimaldi(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Sergio Lodato(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Anna Crispo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Gennaro Ciliberto(Istituti Fisioterapici Ospitalieri), Francesca Pentimalli(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Nicola Maurea(Cancer Institute (WIA)), Alfredo Fucito(Serviço Nacional de Aprendizagem Comercial), Emanuela Esposito(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Maurizio Montella(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Giuseppe D’Aiuto(Memorial Sloan Kettering Cancer Center), Giuseppe Brillante(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 43
Related Papers
Curcumin and Cancer
|Nutrients|2019|977
Role of p53 in the Regulation of Cellular Senescence
|Biomolecules|2020|605
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Tamoxifen for the Prevention of Breast Cancer: Late Results of the Italian Randomized Tamoxifen Prevention Trial Among Women With Hysterectomy
|JNCI Journal of the National Cancer Institute|2007|242